Nav: Home

Study describes potential clinical test and treatment for preterm birth

March 09, 2017

CINCINNATI - Scientists identified a molecular driver of inflammation that may finally answer a key question about what causes mild systemic prenatal infections to trigger preterm birth.

The finding is an important step to developing a treatment or clinical test for early detection of an entrenched global health problem, according to researchers at Cincinnati Children's Hospital Medical Center, who report their data March 9 in The Journal of Clinical Investigation Insight (JCI Insight).

Researchers implicate a molecular signaling receptor that helps regulate the immune system called type I Interferon receptor (IFNAR). INFAR signaling induces infection-driven preterm birth, the authors report. The problem starts in pregnant mothers that develop systemic viral and bacterial infections that are considered subclinical - or not severe enough to present definite or readily observable symptoms.

The researchers show that during these infections, engagement of INFAR receptors on the surface of blood immune cells by the immune protein type I Interferon (type I IFN) fuels production of pro-inflammatory cytokines during secondary inflammatory challenge. This induces preterm birth.

"Preterm birth is a leading worldwide cause of illness and death in infants," says Senad Divanovic, PhD, lead scientific investigator on the study and a member of Division of Immunobiology. "The biological processes linked to the ability of pathogens to help cause preterm birth have been unknown. Identifying active type I IFN/IFNAR as an immunological driver provides an actionable biomarker and potential therapeutic target for reducing preterm birth risk in these circumstances."

Although inflammation from microbial infection is a known factor in preterm birth, it isn't known why a subset of microbes causes the problem. The authors note that not all microbes found in the maternal and fetal tissues of pregnant women induce preterm birth - suggesting the difference is in underlying biological triggers.

To find these triggers, authors of the current study tested induced preterm birth in mouse models and analyzed blood and uterine cell samples from Rhesus monkeys, as well as donated human tissues, to look for biological indicators of type I IFN/IFNAR.

Conserved Mammalian Processes

Despite differences among mammals in the biology of pregnancy and birth, animal models have been useful for studying the molecular processes involved in immune regulation of preterm birth. Unlike the action of giving birth, regulation of the immune process is fairly conserved and similar among different species of mammals, according to the research team. In fact, the current study shows that type I Interferon priming of inflammatory cells is highly conserved among murine, non-human primates and human immune cells in a secondary inflammatory challenge, such as pro-inflammatory cytokine production.

In pregnant wild type mice (those not genetically altered) the researchers tested the role of type I IFN/IFNAR in initial subclinical viral (influenza) infection prior to secondary bacterial inflammation. Notably, initial viral infection prompted activation of type I IFN/IFNAR to fuel an overabundance of systemic pro-inflammatory production of cytokines like Interleukin (IL-6), in the blood and reproductive sites.

PTB Prevention

In tests where researchers genetically deleted type I IFN, IFNAR or IL-6 in mice, or administered neutralizing antibodies to IL-6, the animals were protected from preterm birth, they report.

Divanovic said the research team are now trying to determine exactly where in the body that sensitization of pro-inflammatory pathways and cells initially occurs. They also want to widen the scope of their analyses into different molecular and bacterial processes to determine how broad and persistent regulation of type I IFN is during infections and how such changes modulate increased susceptibility to preterm birth.

Lastly, they want to test whether targeted inhibition of type I IFN/IFNAR prevents preterm birth in non-human primates and whether such approaches would be useful for clinical testing of preterm birth risk.
-end-
Funding support for the research came in part from: the Cincinnati Children's Perinatal Institute Pilot and Feasibility Award; the Burroughs Wellcome Fund (Preterm Birth Research Grant #1015032); the March of Dimes Prematurity Research Center Ohio Collaborative for an Innovation Catalyst Grant (22-FY16-125); the National Institutes of Health (T32AI118697); and the Cincinnati Children's Perinatal Infection and Inflammation Collaborative.

Cincinnati Children's Hospital Medical Center

Related Preterm Birth Articles:

Makeup of vaginal microbiome linked to preterm birth
In a study of predominantly African-American women -- who have a much higher rate of delivering babies early compared with other racial groups -- researchers at Washington University School of Medicine in St.
Preterm birth linked to higher risk of heart failure
Babies born preterm run a higher risk of heart failure during childhood and adolescence than those born at full term, researchers at Karolinska Institutet in Sweden report.
Low accuracy found for tests used to predict risk of spontaneous preterm birth for women who have not given birth before
The use of two measures, fetal fibronectin (a protein) levels and transvaginal cervical length, had low predictive accuracy for spontaneous preterm birth among women who have not given birth before, according to a study appearing in the March 14 issue of JAMA.
Study describes potential clinical test and treatment for preterm birth
Scientists identified a molecular driver of inflammation that may finally answer a key question about what causes mild systemic prenatal infections to trigger preterm birth.
Vaginal progesterone reduces the rate of preterm birth
Treatment with vaginal progesterone reduced the risk of preterm birth, neonatal complications and death in pregnant women with twins and who have a short cervix -- a risk factor for preterm birth -- according to a meta-analysis of individual patient data by researchers at the National Institutes of Health, the Wayne State University School of Medicine, the Detroit Medical Center, and other institutions in the United States and abroad.
Too little food from animal sources may increase risk of preterm birth
Pregnant women increase their chances of vitamin B12 deficiency if they don't consume enough meat, milk or eggs.
Bacterial membrane vesicles can cause preterm birth
A study published on Sept. 1 in PLOS Pathogens reports that GBS produces membrane-bound vesicles containing bacterial factors that can attack the host tissue.
Study quantifies risk factors for preterm birth
A significant portion of preterm births might be avoided by reducing or eliminating three major risk factors: abnormalities in the interval between pregnancies, the mother's body mass index prior to pregnancy, and the amount of weight gain in pregnancy.
Surgical stitch linked to stillbirth and preterm birth
In a study of almost 700 pregnant women who received a cervical stitch designed to prevent preterm labor, the use of one type of suture over another was associated with three times higher risk of stillbirth and almost twice the risk of preterm birth.
Common diabetes drug may help prevent preterm birth
Metformin, a medication routinely used by millions of people with type 2 diabetes, may also play an unexpected role in blocking a significant cause of preterm birth.

Related Preterm Birth Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#529 Do You Really Want to Find Out Who's Your Daddy?
At least some of you by now have probably spit into a tube and mailed it off to find out who your closest relatives are, where you might be from, and what terrible diseases might await you. But what exactly did you find out? And what did you give away? In this live panel at Awesome Con we bring in science writer Tina Saey to talk about all her DNA testing, and bioethicist Debra Mathews, to determine whether Tina should have done it at all. Related links: What FamilyTreeDNA sharing genetic data with police means for you Crime solvers embraced...